Codexis, Inc.
- CDXS
- NASDAQ
- Biotechnology
- Enzyme Engineering/Biocatalysis
- Protein-Based Solutions
$1.24
Today −8.82%Quote Oct 16, 2026, 08:00 PM UTC
−6.06%over the last month
Max drawdown −12.1%From 1-month high −12.1%3 months −43.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$135.8M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$8.00
+545.2% from here
Floor
$1.22
1.3% below price
Where the price sits
14 analysts
Analyst range, low to high
$5.00$11.00
- Price $1.24
- Resistance $1.28
- Consensus $8.00
The price is just above its floor and right under resistance. Analysts' average target sits about 545% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CDXSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $14.9M
- Product$13.2M88.6%
- Research and Development Revenue$1.7M11.4%
Industry
Biotechnology
Employees
146